Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP251655.RAQcNrofLTCN1Pg2iQz5nLOpQQe9SAKKeFbmMjwf06ScQ130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP251655.RAQcNrofLTCN1Pg2iQz5nLOpQQe9SAKKeFbmMjwf06ScQ130_assertion type Assertion NP251655.RAQcNrofLTCN1Pg2iQz5nLOpQQe9SAKKeFbmMjwf06ScQ130_head.
- NP251655.RAQcNrofLTCN1Pg2iQz5nLOpQQe9SAKKeFbmMjwf06ScQ130_assertion description "[Amphiregulin antisense oligonucleotide inhibits the growth of T3M4 human pancreatic cancer cells and sensitizes the cells to EGF receptor-targeted therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP251655.RAQcNrofLTCN1Pg2iQz5nLOpQQe9SAKKeFbmMjwf06ScQ130_provenance.
- NP251655.RAQcNrofLTCN1Pg2iQz5nLOpQQe9SAKKeFbmMjwf06ScQ130_assertion evidence source_evidence_literature NP251655.RAQcNrofLTCN1Pg2iQz5nLOpQQe9SAKKeFbmMjwf06ScQ130_provenance.
- NP251655.RAQcNrofLTCN1Pg2iQz5nLOpQQe9SAKKeFbmMjwf06ScQ130_assertion SIO_000772 9247297 NP251655.RAQcNrofLTCN1Pg2iQz5nLOpQQe9SAKKeFbmMjwf06ScQ130_provenance.
- NP251655.RAQcNrofLTCN1Pg2iQz5nLOpQQe9SAKKeFbmMjwf06ScQ130_assertion wasDerivedFrom befree-20150227 NP251655.RAQcNrofLTCN1Pg2iQz5nLOpQQe9SAKKeFbmMjwf06ScQ130_provenance.
- NP251655.RAQcNrofLTCN1Pg2iQz5nLOpQQe9SAKKeFbmMjwf06ScQ130_assertion wasGeneratedBy ECO_0000203 NP251655.RAQcNrofLTCN1Pg2iQz5nLOpQQe9SAKKeFbmMjwf06ScQ130_provenance.